The significance of the mutated divalent metal transporter (DMT1) on iron transport into the Belgrade rat brain

Journal of Neurochemistry

Volumn 88, Issue 1, 2004, Pages 233-245

  Moos, Torben ^a,c   Morgan, Evan H ^b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Blood brain barrier; Choroid plexus; Endocytosis; Ferric reductase; Human autopsies; Transferrin receptor

Indexed keywords

NATURAL RESISTANCE ASSOCIATED MACROPHAGE PROTEIN 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; CAPILLARY ENDOTHELIUM; CHOROID PLEXUS; CONTROLLED STUDY; GENE MUTATION; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IRON TRANSPORT; MACROGLIA; MICROGLIA; NONHUMAN; PRIORITY JOURNAL; RAT; RAT STRAIN;

ANIMALIA; RATTUS NORVEGICUS;

EID: 0347993815     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2003.02142.x     Document Type: Article

References (57)

1. Adams J. C. (1992) Biotin amplification of biotin and horseradish peroxidase signals in histochemical stains. J. Histochem. Cytochem. 40, 1457-1463.
2. Bickel U., Yoshikawa T. and Pardridge W. M. (2001) Delivery of peptides and proteins through the blood-brain barrier. Adv. Drug Deliv. Rev. 46, 247-279.
3. Bobrow M. N., Harris T. D., Shaughnessy K. J. and Litt G. J. (1989) Catalyzed reporter deposition, a novel method of signal amplification. Application to immunoassays. J. Immunol. Meth. 125, 279-285.
4. Bowen B. J. and Morgan E. H. (1987) Anemia of the Belgrade rat: evidence for defective membrane transport of iron. Blood 70, 38-44.
5. Bradbury M. W. B. (1997) Transport of iron in the blood-brain-cerebrospinal fluid system. J. Neurochem. 69, 443-454.
6. Broadwell R. D., Baker-Caims B. J., Friden P. M., Oliver C. and Villegas J. C. (1996) Transcytosis of protein through the mammalian cerebral epithelium and endothelium. 111. Receptor-mediated transcytosis through the blood-brain barrier of blood-bome transferrin and antibody against the transferrin receptor. Exp. Neurol. 142, 47-65.
7. Burdo J. R., Menzies S. L., Simpson I. A., Garrick L. M., Garrick M. D., Dolan K. G., Haile J. L. and Connor J. R. (2001) Distribution of divalent metal transporter 1 and metal transporter protein 1 in the normal and Belgrade rat. J. Neurosci. Res. 66, 1198-1207.
8. Canonne-Hergaux F. and Gros P. (2002) Expression of the iron transporter DMT1 in kidney from normal and anemic mk mice. Kidney Int. 62, 147-156.
9. Crowe A. and Morgan E. H. (1992) Iron and transferrin uptake by brain and cerebrospinal fluid in the rat. Brain Res. 592, 8-16.
10. Davson H. and Segal M. B. (1996) Acid-base relations in the CNS, in Physiology of the CSF and Blood-Brain Barriers, pp. 459-488. CRC Press, Boca Raton.
11. Edwards J. A., Garrick L. M. and Hoke J. E. (1978) Defective iron uptake and globin synthesis by erythroid cells in the anemia of the Belgrade laboratory rat. Blood 51, 347-357.
12. Farcich E. A. and Morgan E. H. (1992) Diminished iron acquisition by cells and tissues of Belgrade laboratory rats. Am. J. Physiol. Heart Circ. Physiol. 262, R220-R224.
13. Ferguson C. J., Wareing M., Ward D. T., Green R., Smith C. P. and Riccardi D. (2001) Cellular localization of divalent metal transporter DMT-1 in rat kidney. Am. J. Physiol. Renal Physiol. 280, F803-F814.
14. Fishman J. B., Rubin J. B., Handrahan J. V., Connor J. R. and Fine R. E. (1987) Receptor-mediated transcytosis of transferrin across the blood-brain barrier. J. Neurosci. Res. 18, 299-304.
15. Fleming M. D., Trenor C. C., III, Su M. A., Foemzler D., Beier D. R., Dietrich W. F. and Andrews N. C. (1997) Microcytic anaemia mice have a mutation in Nramp2, a candidate iron transporter gene. Nat. Genet. 16, 383-386.
16. Fleming M. D., Romano M. A., Su M. A., Garrick L. M., Garrick, M. D. and Andrews N. C. (1998) Nramp2 is mutated in the anemic Belgrade (b) rat: Evidence of a role for Nramp2 in endosomal iron transport. Proc. Natl Acad. Sci. USA 95, 1148-1153.
17. Gunshin H., Mackenzie B., Berger U. V., Gunshin Y., Romero M. F., Boron W. F., Nussberger S., Gollan J. L. and Hediger M. A. (1997) Cloning and characterization of a mammalian proton-coupled metal-ion transporter. Nature 388, 482-488.
18. Guthrie P. B., Knappenberger J., Segal M., Bennet M. V. L., Charles A. C. and Kater S. B. (1999) ATP released from astrocytes mediates glial calcium waves. J. Neurosci. 19, 520-528.
19. Huang F. P., Xi G., Keep R. F., Hua Y., Nemoianu A. and Hoff J. T. (2002) Brain edema after experimental intracerebral hemorrhage: role of hemoglobin degradation products. J. Neurosurg. 96, 287-293.
20. Hubert N. and Hentze M. W. (2002) Previously uncharacterized isoforms of divalent metal transporter (DMT)-1: implications for regulation and cellular function. Proc. Natl Acad. Sci. USA 99, 12345-12350.
21. International Committee for Standardization in Hematology (1971) Proposed recommendations for measurement of serum iron in human blood. J. Clin. Pathol. 24, 334-335.
22. Johanson C. E., Palm D. E., Primiano M. J., McMillan P. N., Chan P., Knuckey N. W. and Stopa E. G. (2000) Choroid plexus recovery after transient forebrain ischemia: role of growth factors and other repair mechanisms. Cell. Mol. Biol. 20, 197-216.
23. Kaldor I. (1954) Studies on intermediary iron metabolism. V. The measurement of non-hemoglobulin tissue iron. Aust. J. Exp. Biol. Med. Sci. 32, 795-800.
24. Klomp L. W. J., Farhangrazi Z. S., Dugan L. L. and Gitlin J. D. (1996) Ceruloplasmin gene expression in the murine central nervous system. J. Clin. Invest. 98, 207-215.
25. Kühn L. C. (1998) Iron and gene expression: Molecular mechanisms regulating cellular iron homeostasis. Nut. Rev. 56, S11-S19.
26. Laskey J., Webb I., Schulman H. M. and Ponka P. (1988) Evidence that transferrin supports cell proliferation by supplying iron for DNA synthesis. Exp. Cell Res. 176, 87-95.
27. LaVaute T., Smith S., Cooperman S. et al. (2001) Targeted deletion of the gene encoding iron regulatory protein-2 causes misregulation of iron metabolism and neurodegenerative disease in mice. Nat. Genet. 27, 209-214.
28. McKie A. T., Barrow D., Latunde-Dada G. O. et al. (2001) An iron-regulated ferric reductase associated with the absorption of dietary iron. Science 291, 1755-1759.
29. Miyajima H., Nishimura Y., Mizoguchi K., Sakamoto M., Shimizu T. and Honda N. (1987) Familial apoceruloplasmin deficiency associated with blepharospasm and retinal degeneration. Neurology 37, 761-767.
30. Miyajima H., Kono S., Takahashi Y. and Sugimoto M. (2002) Increased lipid peroxidation and mitochondrial dysfunction in aceruloplasminemia brains. Blood Cell Mol. Dis. 29, 433-438.
31. Moos T. and Morgan E. H. (1998) Evidence for low molecular weight, non-transferrin-bound iron in rat brain and cerebrospinal fluid. J. Neurosci. Res. 54, 486-494.
32. Moos T. and Morgan E. H. (2000) Transferrin and transferrin receptor function in brain barrier systems. Cell. Mol. Neurobiol. 20, 77-95.
33. Moos T., Oates P. S. and Morgan E. H. (1998) Expression of the neuronal transferrin receptor is age dependent and susceptible to iron deficiency. J. Comp. Neurol. 398, 420-430.
34. Moos T., Trinder D. and Morgan E. H. (2000) Cellular distribution of ferric iron, ferritin, transferrin and divalent metal transporter 1 (DMT1) in substantia nigra and basal ganglia of normal and beta2-microglobulin deficient mouse brain. Cell. Mol. Biol. 46, 549-561.
35. Morgan E. H. (1977) Iron exchange between transferrin molecules mediated by phosphate compounds and other cell metabolites. Biochim. Biophys. Acta 499, 169-177.
36. Morgan E. H. (1979) Studies on the mechanism of iron release from transferrin. Biochim. Biophys. Acta 580, 312-326.
37. Morgan E. H. (1983) Effect of pH and iron content of transferrin on its binding to reticulocyte receptors. Biochim. Biophys. Acta 762, 498-502.
38. Morgan E. H. and Moos T. (2002) Mechanism and developmental changes in iron transport across the blood-brain barrier. Dev. Neurosci. 24, 106-113.
39. Neary J. T., Rathbone M. P., Cattabeni F., Abbracchio M. P. and Burnstock G. (1996) Trophic actions of extracellular nucleotides and nucleosides on glial and neuronal cells. Trends Neurol. Sci. 19, 13-18.
40. Oates P. S. and Morgan E. H. (1996) Defective iron uptake by the duodenum of the Belgrade rat fed diets of different iron contents. Am. J. Physiol. Gastrointest. Liver Physiol. 270, G826-G832.
41. Pardridge W. M., Eisenberg J. and Yang J. (1987) Human blood-brain barrier transferrin receptor. Metabolism 36, 892-895.
42. Patel B. N. and David S. (1997) A novel glycosylphosphatidylinositol-anchored form of ceruloplasmin is expressed by mammalian astrocytes. J. Biol. Chem. 272, 20185-20190.
43. Patel B. N., Dunn R. J., Jeong S. Y., Zhu Q., Julien J. P. and David S. (2002) Ceruloplasmin regulates iron levels in the CNS and prevents free radical injury. J. Neurosci. 22, 6578-6586.
44. Petroff O. A., Yu R. K. and Ogino T. (1986) High-resolution proton magnetic resonance analysis of human cerebrospinal fluid. J. Neurochem. 47, 1270-1276.
45. Ponting C. P. (2001) Domain homologues of dopamine beta-hydroxylase and ferric reductase: roles for iron metabolism in neurodegenerative disorders? Hum. Mol. Genet. 10, 1853-1858.
46. Qian Z. M. and Shen X. (2001) Brain iron transport and neurodegeneration. Trends Mol. Med. 7, 103-108.
47. Roth J. A., Horbinski C., Feng L., Dolan K. G., Higgins D. and Garrick M. D. (2000) Differential localization of divalent metal transporter 1 with and without iron response element in rat PC12 and sympathetic neuronal cells. J. Neurosci. 20, 7595-7601.
48. Rouault T. (2001) Systemic iron metabolism: a review and implications for brain iron metabolism. Ped. Neurol. 25, 130-137.
49. Sladic-Simic D., Zivkovic N., Pavic D., Marinkovic D., Martinovic J. and Martinovitch P. N. (1966) Hereditary hypochromic microcytic anemia in the laboratory rat. Genetics 53, 1079-1089.
50. 13C]NMR spectroscopy of cultured neurons and astrocytes. Neurosci. Lett. 128, 235-239.
51. Taylor E. M., Crowe A. and Morgan E. H. (1991) Transferrin and iron uptake by the brain: Effects of altered iron status. J. Neurochem. 57, 1584-1592.
52. Triguero D., Buciak J. and Pardridge W. M. (1990) Capillary depletion method for quantification of blood-brain barrier transport of circulating peptides and plasma proteins. J. Neurochem. 54, 1882-1888.
53. Trinder D., Oates P. S., Thomas C., Sadleir J. and Morgan E. H. (2000) Localization of divalent metal transporter 1 (DMT1) to the microvillus membrane of rat duodenal enterocytes in iron deficiency, but to hepatocytes in iron overload. Gut 46, 270-276.
54. Wang X. S., Ong W. Y. and Connor J. R. (2001) A light and electron microscopic study of the iron transporter protein DMT-1 in the monkey cerebral neocortex and hippocampus. J. Neurocytol. 30, 353-360.
55. Wang X. S., Ong W. Y. and Connor J. R. (2002) A light and electron microscopic study of divalent metal transporter-1 distribution in the rat hippocampus, after kainate-induced neuronal injury. Exp. Neurol. 177, 193-201.
56. Zhang Y. and Pardridge W. M. (2001) Rapid transferrin efflux from brain to blood across the blood-brain barrier. J. Neurochem. 76, 1597-1600.
57. Zhou B., Westaway S. K., Levinson B., Johnson M. A., Gitschier J. and Hayflick S. J. (2001) A novel pantothenate kinase gene (PANK2) is defective in Hallervorden-Spatz syndrome. Nat. Genet. 28, 345-349.